DrugPatentWatch Database Preview

NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Normosol-r And Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Normosol-r And Dextrose 5% In Plastic Container is a drug marketed by Icu Medical Inc and is included in one NDA.

The generic ingredient in NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate profile page.

Summary for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

US Patents:	0
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Clinical Trials:	1
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed

Pharmacology for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

Ingredient-type	Potassium Compounds
Drug Class	Osmotic Laxative Potassium Salt Calculi Dissolution Agent
Mechanism of Action	Osmotic Activity Magnesium Ion Exchange Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Inhibition Small Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion

US Patents and Regulatory Information for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Icu Medical Inc	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate	INJECTABLE;INJECTION	017609-001	Approved Prior to Jan 1, 1982		RX	No	No